Price signalling

Articles Written by

On 24 November 2011, the Senate passed the Competition and Consumer Amendment Bill (No. 1) 2011 which introduces new prohibitions against disclosures of pricing and other competitively sensitive information. The new law will take effect six months after the Bill receives Royal Assent (most likely in June 2012).

The new law prohibits two types of price signalling, subject to a number of exceptions:

  • private disclosures of pricing information to competitors, irrespective of the purpose of the disclosure or its likely effect on competition; and
  • public or private disclosures of information about prices, capacity or strategy for the purpose of substantially lessening competition.

Regulations specifying the particular goods and services to which the new law will apply are still to be released. The Government has stated its intention that the new prohibitions will initially only apply to the banking sector, but has left open the possibility of extending it to other industry sectors in the future.

Important Disclaimer: The material contained in this article is comment of a general nature only and is not and nor is it intended to be advice on any specific professional matter. In that the effectiveness or accuracy of any professional advice depends upon the particular circumstances of each case, neither the firm nor any individual author accepts any responsibility whatsoever for any acts or omissions resulting from reliance upon the content of any articles. Before acting on the basis of any material contained in this publication, we recommend that you consult your professional adviser. Liability limited by a scheme approved under Professional Standards Legislation (Australia-wide except in Tasmania).

Related insights Read more insight

Anti-competitive disparagement: think twice before you criticise your competitors’ products

The European Commission recently fined a large global pharmaceutical company €462.6 million for abusing its dominant position to lessen competition in the market for the supply of Copaxone...

More
Do you need to disclose an ACCC investigation to comply with your continuous disclosure obligations?

Recent cases have highlighted whether an ASX-listed entity must make a market disclosure to the ASX if it receives a confidential compulsory investigation notice under section 155 of the...

More
Preliminary discovery – the neat trick that allows you to obtain another party's documents

In recent years, several cases have involved a party seeking preliminary discovery against another party to determine whether to commence proceedings against that party for conduct that breaches...

More